(S)-5-(TERT.-BUTYLDIPHENYLSILOXYMETHYL)-1-(PHENYLMETHYL)-2-PYRROLIDINONE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | IlUmHP1dhhn |
|---|---|
| InChI | InChI=1S/C28H33NO2Si/c1-28(2,3)32(25-15-9-5-10-16-25,26-17-11-6-12-18-26)31-22-24-19-20-27(30)29(24)21-23-13-7-4-8-14-23/h4-18,24H,19-22H2,1-3H3/t24-/m0/s1 |
| InChIKey | OXFKAXZLFHKXJZ-DEOSSOPVSA-N |
| Mol Weight | 443.7 g/mol |
| Molecular Formula | C28H33NO2Si |
| Exact Mass | 443.228056 g/mol |
| Enantiomer InChIKey | OXFKAXZLFHKXJZ-XMMPIXPASA-N |
| Racemate InChIKey | OXFKAXZLFHKXJZ-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(5RS)-1-[(1R)-1-(TERT.-BUTYLDIPHENYLSILYLOXYMETHYL)-ALLYL]-5-HYDROXYPYRROLIDIN-2-ONE;ISOMER-A
(2R)-2-(tert-Butyldiphenylsilyloxymethyl)-1-azabicyclo[2.2.2]octan-5-one
(2S)-2-(tert-Butyldiphenylsilyloxymethyl)-1-azabicyclo[2.2.2]octan-5-one
(2S)-2-(tert-Butyldiphenylsilyloxymethyl)-1-azabicyclo[2.2.2]octan-5-ol
(2R)-2-(tert-Butyldiphenylsilyloxymethyl)-1-azabicyclo[2.2.2]octan-5-ol
(2S)-2-[(tert-Butyldiphenylsilyloxy)methyl]-1-(benzyloxycarbonyl)-4-pyrroline
(4S)-ETHYL-(E)-4-(2-CHLORO-2-PHENYLETHANAMIDO)-5-(TERT.-BUTYLDIPHENYLSILYLOXY)-PENT-2-ENOATE
tert-Butyl-[(3R,5R)-5-fluoranyl-1-(phenylmethyl)piperidin-3-yl]oxy-diphenyl-silane
(3R,5R)-1-Benzyl-5-(tert-butyldiphenylsilyloxy)piperidin-3-amine
Benzyl 6-O-(tert-Butyldiphenylsilyl)-3,4-dideoxy-2-O-methyl-.alpha.-D-erythro-hexopyranoside
| Title | Journal or Book | Year |
|---|---|---|
| Electrophilic Fluorination of Pyroglutamic Acid Derivatives: Application of Substrate-Dependent Reactivity and Diastereoselectivity to the Synthesis of Optically Active 4-Fluoroglutamic Acids | The Journal of Organic Chemistry | 2001 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.